Skip to content

N-acetyl cysteine may support dopamine neurons in Parkinson’s disease: Preliminary clinical and cell line data

The overall objective of this pilot study was to obtain additional data on potential protective properties of NAC in PD using an in vitro and in vivo approach. In preparation for the clinical trial, we performed a cell tissue culture study using human embryonic stem cell (hESC)-derived midbrain dopamine neurons (mDA) treated with rotenone as a model for PD.

The primary outcome in the cell tissue cultures was the number of cells that survived the insult with the neurotoxin rotenone. In the clinical trial, patients continued standard treatment and were randomized to receive either daily NAC or to be placed on the waiting list. Patients were assessed before and at 3 months after receiving NAC using DaTscan to measure dopamine transporter (DAT) binding and the Unified Parkinson’s Disease Rating Scale (UPDRS) to measure clinical symptoms.

The results of this preliminary study show for the first time a possible direct effect of NAC on the dopamine system in Parkinson’s disease patients, and this observation may be associated with positive clinical effects. A large-scale clinical trial to test the therapeutic efficacy of NAC in this population and to better elucidate the mechanism of action is warranted.

PLOS ONE: N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson’s Disease: Preliminary Clinical and Cell Line Data

Powered by BetterDocs

Close Popup

Bye bye booze needs a few cookies, too.

However, we try only to activate as few as possible technically necessary cookies so that your visit to this site cannot be tracked as far as possible by third parties. We do not share any information about your visit with anyone.

But even we we do need a few - e.g. to display this legal notice or to care for that you do not have to log in again for each page or see this popup again for each page.

As soon as you click on an external link or video, cookies may be set by the operators of these sites, which we cannot influence. Learn more on our privacy page.

Close Popup